 Zidovudine myopathy distinctive disorder mitochondrial dysfunction Muscle biopsy specimens human immunodeficiency virus-infected patients various neuromuscular symptoms Microscopic examination conventional electron microscopy characteristic structural myopathy mitochondrial changes patients long-term zidovudine therapy mean cumulative dose gm zidovudine recipients study progressive painful proximal myopathy pronounced wasting elevated creatine kinase levels myopathic electromyographic pattern condition withdrawal drug Assay mitochondrial enzymes succinate-cytochrome reductase cytochrome oxidase citrate synthase decline respiratory chain capacity Southern blot analysis mitochondrial DNA abnormality likely mitochondrial dysfunction drug-induced inhibition mitochondrial DNA polymerase pathogenesis complication zidovudine therapy